 |
|
|
|
|
| |
 |
|
|
| |
Boston Millennia Partners’ portfolio reflects Millennia’s commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors. Millennia’s portfolio is comprised of a diversified group of firms each positioned with the potential to become leaders in their respective market segments. We invite you to use the links below to learn more about each of those portfolio companies. |
|
| |
|
|
| |
| |
|
| |
|
|
200 West Street
Waltham, MA 02451-1163
Phone: 781 487 9900
|
|
| |
| |
PAREXEL is a public Core Company formed as a global, full service Contract Research Organization (CRO) specializing in comprehensive clinical trials management, biostatistical consultation, and regulatory submissions for pharmaceutical, biotechnology, medical device, and other health related industries. Public since November, 1995 (Nasdaq: PRXL). |
|
| |
|
| Millennia Team |
Dana Callow,
Pat Fortune, Ph.D.
|
|
| Visit the Website |
http://www.parexel.com/ |
|
| Case Study |
PAREXEL International is a global contract
research organization providing clinical trials outsourcing services to major pharmaceutical companies worldwide. We worked with PAREXEL’s founders to grow the company from a niche market consulting firm into a multinational pharmaceutical services company generating more than $1 billion in annual revenue. Following our initial investment in 1986, we worked with PAREXEL’s management team to define and implement a strategy to consolidate the highly fragmented contract research industry and take advantage of its extraordinary growth potential. We developed primary market research for PAREXEL on the contract research organization industry and created a database of acquisition candidates, from which the company completed several acquisitions. PAREXEL is now the third largest contract research organization in the world, with over 7,000 employees. PAREXEL completed its initial public offering in November 1995. The distributed value of our $2.8 million investment in PAREXEL was $38.6 million.
Download Attachment >
|
|
| Related News |
Boston, MA - June 1, 2009
PAREXEL Named as One of the Top 10 Publicly Traded Companies Based in Massachusetts
Boston, MA - August 5, 2008
PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Boston, MA, July 22, 2008
ClinPhone Shareholders Approve Acquisition by PAREXEL
Boston, MA - June 13, 2008
PAREXEL Reaches Agreement to Acquire ClinPhone
Boston, MA - January 25, 2008
PAREXEL Hits New Peak Market Cap of $1.6 Billion
|
|
|
|
|
|
|
|
|
|
